CHEBI:61272 - scopolamine hydrobromide trihydrate

ChEBI IDCHEBI:61272
ChEBI Namescopolamine hydrobromide trihydrate
Stars
DefinitionA hydrate that is the trihydrate form of scopolamine hydrobromide.
Last Modified27 June 2011
SubmitterGareth Owen
DownloadsMolfile
FormulaC17H21NO4.3H2O.HBr
Net Charge0
Average Mass438.315
Monoisotopic Mass437.10491
SMILESBr.CN1[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12.O.O.O
InChIInChI=1S/C17H21NO4.BrH.3H2O/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10;;;;/h2-6,11-16,19H,7-9H2,1H3;1H;3*1H2/t11-,12-,13-,14+,15-,16+;;;;/m1..../s1
InChIKeyLACQPOBCQQPVIT-SEYKEWMNSA-N
Roles Classification
Biological Role:
muscarinic antagonist  A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists.
Applications:
antispasmodic drug  A drug that suppresses spasms. These are usually caused by smooth muscle contraction, especially in tubular organs. The effect is to prevent spasms of the stomach, intestine or urinary bladder.
antiemetic  A drug used to prevent nausea or vomiting. An antiemetic may act by a wide range of mechanisms: it might affect the medullary control centres (the vomiting centre and the chemoreceptive trigger zone) or affect the peripheral receptors.
muscarinic antagonist  A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists.
mydriatic agent  Agent that dilates the pupil. Used in eye diseases and to facilitate eye examination. It may be either a sympathomimetic or parasympatholytic. The latter cause cycloplegia or paralysis of accommodation at high doses and may precipitate glaucoma.
anaesthesia adjuvant  Any substance that possesses little anaesthetic effect by itself, but which enhances or potentiates the anaesthetic action of other drugs when given at the same time.
ChEBI Ontology
Outgoing Relation(s)
scopolamine hydrobromide trihydrate (CHEBI:61272) has part scopolamine hydrobromide (anhydrous) (CHEBI:61271)
scopolamine hydrobromide trihydrate (CHEBI:61272) has role anaesthesia adjuvant (CHEBI:60807)
scopolamine hydrobromide trihydrate (CHEBI:61272) has role antiemetic (CHEBI:50919)
scopolamine hydrobromide trihydrate (CHEBI:61272) has role antispasmodic drug (CHEBI:53784)
scopolamine hydrobromide trihydrate (CHEBI:61272) has role muscarinic antagonist (CHEBI:48876)
scopolamine hydrobromide trihydrate (CHEBI:61272) has role mydriatic agent (CHEBI:50513)
scopolamine hydrobromide trihydrate (CHEBI:61272) is a hydrate (CHEBI:35505)
IUPAC Names 
(1R,2R,4S,5S,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate hydrobromide—water (1/3)
(1R,2R,4S,5S,7s,9s)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide—water (1/3)
Synonyms  Source
scopolamine hydrobromideChemIDplus
hyoscine hydrobromide trihydrateChemIDplus
(−)-scopolamine hydrobromide trihydrateChemIDplus
scopolammonium bromide trihydrateChEBI
scopolaminium bromide trihydrateChEBI
Brand Names  Source
HyscoKEGG DRUG
Isopto hyoscineKEGG DRUG
Manual XrefsDatabases
DB00747DrugBank
D02071KEGG DRUG
Registry NumbersSources
CAS:6533-68-2KEGG DRUG
CAS:6533-68-2ChemIDplus